Neuren Pharmaceuticals Ltd (NEU) — Free Cash Flow Generation Index
Neuren Pharmaceuticals Ltd (NEU) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of AU$128.30 Million represents 1% of operating cash flow (AU$128.31 Million). See Neuren Pharmaceuticals Ltd (NEU) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Neuren Pharmaceuticals Ltd Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for Neuren Pharmaceuticals Ltd across 3 annual periods. Explore how well can Neuren Pharmaceuticals Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Neuren Pharmaceuticals Ltd (2018–2023)
Year-by-year Free Cash Flow Generation Index for Neuren Pharmaceuticals Ltd. For the full company profile including market capitalisation, see Neuren Pharmaceuticals Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (AUD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.00x | AU$184.88 Million | AU$184.93 Million | AU$40.00K | ▲ +0.5% |
| 2022 | 0.99x | AU$3.58 Million | AU$3.60 Million | AU$19.00K | ▼ -0.5% |
| 2018 | 1.00x | AU$6.41 Million | AU$6.41 Million | AU$12.00K | — |